Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults

A live attenuated zoster vaccine (ZOSTAVAX™, Merck & Co., Inc.) was approved by the Korea Ministry of Food and Drug Safety in 2009. However, the immunogenicity and safety of the vaccine has not been assessed in Korean population. This is multi-center, open-label, single-arm study performed with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Korean Med Sci
Hlavní autoři: Choi, Won Suk, Choi, Jung-Hyun, Choi, Jun Yong, Eom, Joong Sik, Kim, Sang Il, Pai, Hyunjoo, Peck, Kyong Ran, Sohn, Jang Wook, Cheong, Hee Jin
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Academy of Medical Sciences 2016
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4712571/
https://ncbi.nlm.nih.gov/pubmed/26770032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2016.31.1.13
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky